CircERC1 Facilitates Chemoresistance through Inhibiting Pyroptosis and Remodeling Extracellular Matrix in Pancreatic Cancer

0
1574
Scientists revealed a novel circERC1 as a key regulator in pancreatic ductal adenocarcinoma-secreted EVs following paclitaxel treatment, thereby inhibiting gemcitabine/Nab-paclitaxel induced pyroptosis.
[Molecular Cancer]
Full Article